Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zhejiang Chang'an Renheng Technology Co., Ltd. (8139.HK)
Changxing, CN
Zhejiang Chang'an Renheng Technology Co., Ltd., along with its subsidiaries, specializes in the development, manufacturing, and sale of advanced bentonite fine chemicals within the People's Republic of China. Their product range is extensive, featuring chemicals for papermaking, various inorganic gels, bentonite specifically designed for metallurgical pellets, premium calcium-bentonite, organic bentonite derivatives, and other chemical agents like flocculants, primarily utilized in the coating preparation sector. The company also extends its operations to include clay mining and processing, in addition to the wholesale and retail distribution of chemicals and equipment. Established in 2000, the firm was originally known as Changxing Renheng Fine Bentonite Co., Ltd. until its rebranding to Zhejiang Chang'an Renheng Technology Co., Ltd. in December 2008. Its headquarters are located in Changxing, People's Republic of China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.97% | -3.97% | -12.32% | -5.47% | -23.42% | -16.55% | -12.95% | +21.00% | -45.00% | -74.79% | -88.48% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Chemicals: +4.0%+6.5% ★ Q4'25: +5.5% (vs Q4'24)
-
EPS growth Chemicals: +11.7%-106.1% Q4'25: +290.5% (vs Q4'24)
-
FCF margin FCF growth · Chemicals: +41.7%-4.4% Q4'25: -10.1% (vs Q4'24)
-
EBIT margin Chemicals: +7.1%+1.2% Q4'25: +1.3% (vs Q4'24)
-
ROIC Chemicals: +3.4%+0.6% Q4'25: +0.9% (vs Q4'24)
-
Share dilution Chemicals: +0.0%+0.0% Q4'25: +0.0% (vs Q4'24)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×9.80× Q4'25: 7.08× (vs Q4'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Youlian Zhang | Executive Chairman | 588.1K | male |
| Qinwei Xu | General Manager | 577.6K | female |
| Wenjie She | Executive Director | 398.2K | male |
| Wan Chan | Company Secretary | 395.2K | male |
| Fang Fan | Head of the Finance Department, Financial Controller, Compliance Officer & Executive Director | 323.4K | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 8139.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
